From 1st July 1 2023, the TGA will permit medicines containing MDMA and psilocybin be prescribed by authorised psychiatrists for people with specific mental health conditions.

This comes as a result of emerging evidence supporting the use of these medicines to treat patients with treatment resistant post traumatic stress disorder and  depression, where other medicines and therapies haven’t been effective.   

Read more to understand the strict controls that will surround these upcoming changes.